According to Spero Therapeutics's latest financial reports the company's current earnings are A$89.86 Million. In 2023 the company made an earning of A$44.45 Million, an increase over its 2022 earnings that were of -A$69.98 Million. The earnings displayed on this page is the company's Pretax Income.